In differentiated HL-60 neutrophil-like cells, MRP1- (ABCC1-) mediated glutathione efflux stimulated by BzATP and P2X7 receptor signalling regulates exosome release through nSMase activity

In differentiated HL-60 neutrophil-like cells, BzATP-activated P2X7 receptor signaling triggers a PI3K/AKT-MRP1-dependent pathway that depletes intracellular glutathione to activate nSMase, thereby driving ceramide-mediated exosome biogenesis as a mechanism for translating inflammatory cues into vesicle communication.

The Gist

The Big Picture: Neutrophils Sending "Emergency Texts"

Imagine your body is a bustling city, and neutrophils are the police officers patrolling the streets. Their job is to rush to the scene of a crime (an infection or injury) and fight off the bad guys.

Sometimes, these police officers need to call for backup or warn other officers nearby. They do this by sending out tiny, sealed envelopes called exosomes. These aren't just empty envelopes; they are packed with "intelligence" (proteins and messages) that tell other cells what's happening.

This paper asks a simple question: How do these police officers decide to send out these emergency envelopes, and what triggers the process?

The Trigger: The "Danger Siren" (BzATP)

The researchers found that when cells are damaged, they release a chemical called ATP. Think of ATP as a siren or a flare gun going off in the city.

In this study, the scientists used a super-charged version of this siren called BzATP. When the neutrophil-like cells (which are like training-dummy police officers made in a lab) hear this siren, they immediately start packing their "emergency envelopes" (exosomes) to send out.

The Secret Mechanism: The "Redox Gate"

Here is the clever part of the discovery. The paper explains how the siren turns the packing machine on. It involves a chemical tug-of-war inside the cell.

1. The Brake (Glutathione): Inside the cell, there is a chemical called Glutathione (let's call it the "Brake"). Normally, this Brake sits on the foot of a machine called nSMase (the "Envelope Maker"). As long as the Brake is there, the machine is off, and no envelopes are made.
2. The Release (MRP1 Pump): When the "Siren" (BzATP) sounds, it wakes up a specific pathway (PI3K/AKT) that activates a pump called MRP1. Think of MRP1 as a vacuum cleaner or a trash chute.
3. The Action: The MRP1 pump sucks the "Brake" (Glutathione) out of the cell and dumps it outside.
4. The Result: With the Brake removed, the "Envelope Maker" (nSMase) is free to run wild! It starts churning out ceramide (a type of fat) which helps form the envelopes. Suddenly, the cell is flooding the neighborhood with exosomes.

The Chain Reaction (In Simple Steps)

1. The Alarm: A damaged cell releases ATP (the siren).
2. The Signal: The neutrophil hears the siren via a receptor (P2X7R).
3. The Pump: The cell activates a pump (MRP1) to throw out its internal "Brake" (Glutathione).
4. The Unleashing: Without the Brake, the "Envelope Maker" (nSMase) turns on.
5. The Delivery: The cell releases a burst of exosomes to communicate the danger to the rest of the immune system.

Why Does This Matter?

This is a double-edged sword:

• The Good: This is how our immune system communicates quickly during an infection. It helps coordinate the defense.
• The Bad: In diseases like severe sepsis, autoimmune disorders, or chronic lung disease, this system gets stuck in the "ON" position. The cells keep pumping out too many exosomes, causing a "cytokine storm" (a massive, uncontrolled inflammation) that damages the body's own organs.

The Takeaway

The researchers discovered a specific "switch" in the cell. By understanding that the MRP1 pump is the key to removing the Brake, they found a potential new way to treat dangerous inflammation.

If we can build a "lock" for that pump (using drugs that stop MRP1), we might be able to stop the neutrophils from sending out too many emergency messages, effectively calming down an overactive immune system without shutting it down completely.

In short: The paper shows that neutrophils use a "trash chute" to throw out their internal brakes, allowing them to rapidly send out emergency messages when they sense danger. Stopping this chute could help treat diseases where the immune system goes into overdrive.

Technical Summary

1. Problem Statement

Extracellular vesicles (EVs), specifically exosomes, are critical mediators of intercellular communication in immune regulation and inflammation. However, the molecular mechanisms governing ESCRT-independent exosome biogenesis in neutrophils remain poorly defined. While the role of extracellular ATP (eATP) and P2X7 receptors (P2X7R) in neutrophil activation is known, the specific signaling cascade linking purinergic stimulation to the redox regulation of exosome formation is unclear. The study aims to elucidate how purinergic signaling intersects with redox regulation to control exosome biogenesis in neutrophil-like cells (NLCs).

2. Methodology

The researchers utilized a robust experimental model and a multi-faceted approach to characterize the pathway:

• Cell Model: Human promyelocytic leukemia (HL-60) cells were differentiated into neutrophil-like cells (NLCs) using all-trans retinoic acid (ATRA) and dimethyl sulfoxide (DMSO) for 5 days. Differentiation was validated by increased CD11b, decreased CD71, enhanced phagocytosis, ROS generation, and cell-cycle arrest.
• Stimulation: NLCs were stimulated with BzATP (a high-affinity P2X7R agonist) at concentrations up to 300 μM to mimic danger signals (eATP) found in inflammatory microenvironments.
• Exosome Isolation & Characterization:
  • Isolation: Differential centrifugation followed by immunoaffinity capture using CD63-biotin antibodies and magnetic beads.
  • Validation: Exosomes were confirmed to meet MISEV 2023 criteria via:
    • Immuno-TEM: Visualizing "cup-shaped" morphology and CD9/CD63 presence.
    • NTA (Nanosight Tracking Analysis): Measuring size distribution (peak modal size ~112 nm).
    • Density Gradient: Buoyant density of 1.10–1.12 g/ml.
    • Western Blotting: Positive for CD63 and Alix; negative for GM130 (Golgi marker).
• Biochemical Assays:
  • Glutathione (GSH): Intracellular (iGSH) and extracellular (eGSH) levels measured via ELISA and luminescence assays.
  • Enzyme Activity: Neutral sphingomyelinase (nSMase) activity measured using a coupled enzymatic assay.
  • Signaling & Transport: Calcium influx (Fura-2 AM), ROS production (H2DCFDA), and transporter activity (calcein-AM efflux).
• Pharmacological Inhibition: The study employed specific inhibitors to dissect the pathway:
  • MK-571: MRP1/ABCC1 transporter inhibitor.
  • MK-2206: PI3K/AKT inhibitor.
  • GW4869: nSMase inhibitor.
  • A740003: P2X7R antagonist.

3. Key Contributions

The paper defines a novel, previously uncharacterized signaling axis in neutrophils:

1. Redox Gating of Exosome Biogenesis: It establishes that the depletion of intracellular glutathione (iGSH) acts as a molecular switch to activate nSMase, driving exosome formation.
2. The PI3K/AKT–MRP1 Axis: It identifies that P2X7R activation triggers a PI3K/AKT signaling cascade that stimulates the MRP1 (ABCC1) transporter.
3. Mechanistic Link: It demonstrates that MRP1-mediated efflux of iGSH relieves the endogenous inhibition of nSMase, leading to ceramide production and intraluminal vesicle (ILV) formation within multivesicular bodies (MVBs).

4. Key Results

• Cell Differentiation: ATRA/DMSO treatment successfully generated NLCs with hallmark neutrophil features (high CD11b, low CD71, high phagocytosis, and P2X7R expression).
• BzATP-Induced Exosome Release: Stimulation with BzATP caused a rapid, dose-dependent increase in exosome release. This release strongly correlated with:
  • A decrease in intracellular GSH (iGSH) ($r = -0.984$).
  • An increase in nSMase activity.
• MRP1 Mediates GSH Efflux: BzATP stimulation triggered the efflux of iGSH and the accumulation of extracellular GSH (eGSH). This process was:
  • Dependent on PI3K/AKT signaling (blocked by MK-2206).
  • Dependent on MRP1 transport activity (blocked by MK-571).
• nSMase is Essential: The increase in nSMase activity following BzATP stimulation was abolished by the nSMase inhibitor GW4869, which also significantly reduced exosome release.
• Causal Chain: The data supports the following sequence:
  $$\text{BzATP} \rightarrow \text{P2X7R} \rightarrow \text{PI3K/AKT} \rightarrow \text{MRP1 Activation} \rightarrow \text{iGSH Efflux} \rightarrow \text{nSMase Disinhibition} \rightarrow \text{Ceramide Production} \rightarrow \text{Exosome Release}$$

5. Significance

• Mechanistic Insight: The study provides a clear molecular mechanism for how neutrophils translate inflammatory "danger signals" (ATP) into rapid vesicle-mediated communication without requiring new gene expression. It highlights a post-translational redox switch (iGSH depletion) controlling lipid metabolism (ceramide synthesis).
• Therapeutic Potential: The identified pathway (P2X7R–PI3K/AKT–MRP1–nSMase) offers specific therapeutic targets. Inhibiting MRP1, PI3K/AKT, or nSMase could potentially dampen excessive neutrophil exosome release in hyperinflammatory conditions such as sepsis, autoimmune diseases, COPD, and cancer, where neutrophil-derived exosomes contribute to tissue damage and chronic inflammation.
• Model Validation: It validates the HL-60 derived NLC model as a reliable surrogate for primary neutrophils in studying complex vesicle biogenesis pathways.

In conclusion, the authors demonstrate that MRP1-mediated glutathione efflux is the critical link between purinergic signaling and the redox-regulated activation of nSMase, driving the rapid biogenesis of exosomes in neutrophils.